郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop.

期刊：Biochemical pharmacology发表年份：2025作者：Riccardo Camilotto; Davide Malfacini; Pietro Pola; Erika Morrone; Alessia Frezza; Rahul Ramalingam; Chiara Sturaro; Salvatore Pacifico; Chiara Ruzza; Remo Guerrini; Garth Whiteside; Girolamo Calo'
阅读更多 →

药效评价Retraction notice to "Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole" [Biomedicine & Pharmacotherapy 167 (2023) 115528].

期刊：Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie发表年份：2026作者：Dušica J Popović; Kosta J Popović; Dejan Miljković; Jovan K Popović; Dušan Lalošević; Mihalj Poša; Zana Dolićanin; Ivan Čapo
阅读更多 →

药效评价Crystal structure of human INPP5K with an allosteric inhibitor reveals the structural basis for species specific potency.

期刊：Scientific reports发表年份：2026作者：Akihiro Nomura; Keishi Yamaguchi; Motoaki Kawano; Kazuki Hanada; Jun Nishihata; Masato Noguchi; Tsuyoshi Adachi
阅读更多 →

药效评价Dual-Similarity Driven Just-in-Time Modeling Enables Precise Real-Time Monitoring of Cell Cultures via Dielectric Spectroscopy.

期刊：Biotechnology journal发表年份：2026作者：Dongliang Chen; Qiongqiong Zhang; Zhe Lang; Zheyu Wang; Xiang Zheng; Mingyue Fang; Hang Zhou
阅读更多 →